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RESULTS CONT.

INTRODUCTION
• Coronaviruses have previously been shown to affect maternal and neonatal
morbidity and mortality.

Ethnicities

• Coronavirus disease 2019 (COVID-19) has been shown to affect vasculature
including placental changes.
• As significant remodeling of the placenta occurs at the end of the first
trimester and into the second trimester, insults during this crucial period
could affect placental functionality, with impact on fetal growth and wellbeing.

Native American

We explored the relationship between antenatally-acquired maternal COVID19 infection and neonatal birth characteristics and hypothesized that
antenatally acquired maternal COVID-19 infections would alter birth
characteristics and, furthermore, that the timing of antenatal infection would
have varying effects on neonatal outcomes.

METHODS
• University of New Mexico Health Sciences Center Data Warehouse queried
for any woman with a positive pregnancy test and positive COVID-19
screening test between 3/1/2020 - 3/24/2021 utilizing ICD-10 codes.
• Women with a positive pregnancy test and negative COVID-19 screening
test or undocumented test without symptoms were also included as a
comparison group.
• Retrospective chart review using University of New Mexico Electronic
Medical Record to obtain maternal and infant characteristics.
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Table 2: Maternal Ethnicities of the study sample.
More CovPos individuals identified as Native American
compared to those individuals that were CovNeg than expected
(21% compared to 12%; p<0.01). Additionally, more CovNeg
individuals identified as white/Caucasian compared to CovPos
than expected (20% compared to 7%; p<0.01).
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• Sample
size included 411 COVID negative (CovNeg) women and 76
VZ
COVID positive (CovPos) women.
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• Statistical significance was defined as p < 0.05.
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RESULTS
Variable
Maternal Age
(average in years)
Gestational Age
(average in weeks)
Birth Weight
(average in grams)
Infant sex
Female
Male
Maternal Tobacco
Use

Covid
Negative
(n=411)
29
38.6
3136

10%

Covid Positive
(n= 76)
29
37.7
3048

P value
0.46

48% (n=198)

50% (n=38)

52% (n=213)

50% (n=38)
6% (n=5)

Graph 2: Delivery
type by COVID
status.
Incidence of delivery
via cesarean section
signific antly more
common in CovPos
cases
compared to
CovNeg
women
(p=0.007).
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Graph 1: Infant admissions at
delivery. Infants were admitted to a
unit other than the newborn nursery
more than expected following birth
to CovPos individuals (p=0.06).
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Table 1: Demographics of the study sample.
There was a significant difference in the average gestational age at delivery with
infants born to CovPos individuals born at an earlier gestational age than those born to
CovNeg individuals (37.7 vs. 38.6 weeks; p<0.01).

• There was a significant difference in gestational age at delivery with
CovPos mothers delivering at a slightly earlier gestational age.
Interestingly, both population delivered at a term gestational age, on
average.
• There was a significant disparity in ethnicities and COVID positive
status. Women who identified as Native American had a higher
incidence of COVID infection during pregnancy.
• CovPos mothers delivered more commonly by C-section compared to
CovNeg mothers. Ongoing analyses are further investigating this
occurrence.
• Infants born to CovPos mothers trended towards requiring admission to
a higher-care unit other than the newborn nursery. Given that both
cohorts were born at term gestation on average, this raises concerns that
the infants born to CovPos mothers may have additional health concerns
after delivery.
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• Data was analyzed via student’s t-test and Chi-square test.

12%

Asian

Unknown

29%

58%

20%

White/Caucasian

Covid Positive (n=76)

Covid
Positive
(n= 76)

52%

Hispanic/Latino

Black/African
American

STUDY OBJECTIVE

Control

Covid
Negative
(n=411)

DISCUSSION

p-value

Graph 3: Growth Parameters of the infant study sample.
aSGA (asymmetrically small for gestational age) defined as birthweight <10th percentile while head
circumference remains 10-90th percentile. SGA (small for gestational age) defined as the birthweight and head
circumference <10th percentile. AGA (appropriate for gestational age) defined as growth parameters between
the 10-90th percentile. LGA (large for gestational age) defined as birth parameters >90th percentile. Odds of
being LGA significantly higher than being AGA or SGA when born to a CovPos mother (OR=4.16 (1.73,9.98)
p=0.001).

• Growth parameters were significantly different between the two groups.
CovPos mothers had more large for gestational age infants than
expected compared to the CovNeg mothers.

SUMMARY
• Multiple differences were present between the maternal and infant
characteristics based on COVID status of the mother in this study
population.
• Additional analyses are currently being conducted to ensure other factors
are not influencing these results.
• Follow up of these infants would be interesting to determine if there are
continued differences in early childhood.
• Additional studies are required to further assess if these results apply to
additional populations.
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